Literature DB >> 11795943

Induction of tubulogenesis in telomerase-immortalized human microvascular endothelial cells by glioblastoma cells.

Eleni Venetsanakos1, Amer Mirza, Christie Fanton, Serguei R Romanov, Thea Tlsty, Martin McMahon.   

Abstract

To facilitate the study of human endothelial cells we have used a replication defective retrovirus encoding the catalytic subunit of telomerase (hTERT) to derive populations of telomerase-immortalized human microvascular endothelial (TIME) cells. Whereas parental HMVECs became senescent on average within 35-45 population doublings (PDs), TIME cells have continued to proliferate for at least 200 PDs. TIME cells express readily detectable telomerase activity but display only a modest increase in telomere length. Karyotypic analysis reveals the cells to have a normal complement of human chromosomes with no evidence of gross genetic abnormalities. Furthermore, TIME cells retain many of the characteristics of the primary endothelial cells from which they were derived. For example, they express a panel of characteristic endothelial cell surface marker proteins such as CD31/PECAM-1 and alpha(v)beta3-integrin. In addition, TIME cells express receptors for low-density lipoprotein (LDL) receptor as they are competent for receptor-mediated endocytosis of fluorescent acetylated LDL. Importantly, when plated on matrigel, TIME cells undergo tubule formation. Moreover, when cocultured in the presence of human glioma cells, but not primary human astrocytes, TIME cells are induced to form stable tubules. Detachment of TIME cells from extracellular matrix leads to a form of programmed cell death known as anoikis. Conditional activation of the protein kinase Akt (Akt:ER*) significantly inhibited the onset of TIME cell anoikis under these conditions. We believe that the ability of hTERT to immortalize primary human endothelial cells, and the fact that such cells retain the endothelial characteristics of the cells from which they were derived, will greatly facilitate the analysis of human endothelial cell biology in vitro. Copyright 2001 Elsevier Science.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11795943     DOI: 10.1006/excr.2001.5424

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  55 in total

1.  The lytic transcriptome of Kaposi's sarcoma-associated herpesvirus reveals extensive transcription of noncoding regions, including regions antisense to important genes.

Authors:  Sanjay Chandriani; Yiyang Xu; Don Ganem
Journal:  J Virol       Date:  2010-06-09       Impact factor: 5.103

2.  Host range of Kaposi's sarcoma-associated herpesvirus in cultured cells.

Authors:  Jill T Bechtel; Yuying Liang; Joshua Hvidding; Don Ganem
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

3.  Inefficient establishment of KSHV latency suggests an additional role for continued lytic replication in Kaposi sarcoma pathogenesis.

Authors:  Adam Grundhoff; Don Ganem
Journal:  J Clin Invest       Date:  2004-01       Impact factor: 14.808

4.  Analysis of protein expression in cell microarrays: a tool for antibody-based proteomics.

Authors:  Ann-Catrin Andersson; Sara Strömberg; Helena Bäckvall; Caroline Kampf; Mathias Uhlen; Kenneth Wester; Fredrik Pontén
Journal:  J Histochem Cytochem       Date:  2006-09-06       Impact factor: 2.479

5.  Paracrine factors released by GATA-4 overexpressed mesenchymal stem cells increase angiogenesis and cell survival.

Authors:  Hongxia Li; Shi Zuo; Zhisong He; Yueting Yang; Zeeshan Pasha; Yigang Wang; Meifeng Xu
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-09-24       Impact factor: 4.733

6.  Induction of angiogenic chemokine CCL2 by human herpesvirus 8 chemokine receptor.

Authors:  Young Bong Choi; John Nicholas
Journal:  Virology       Date:  2009-12-09       Impact factor: 3.616

7.  Identification of proangiogenic genes and pathways by high-throughput functional genomics: TBK1 and the IRF3 pathway.

Authors:  Christian Korherr; Hendrik Gille; Rolf Schäfer; Kerstin Koenig-Hoffmann; Johan Dixelius; Kristi A Egland; Ira Pastan; Ulrich Brinkmann
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-06       Impact factor: 11.205

8.  Bim nuclear translocation and inactivation by viral interferon regulatory factor.

Authors:  Young Bong Choi; John Nicholas
Journal:  PLoS Pathog       Date:  2010-08-05       Impact factor: 6.823

9.  Genetic and pharmacological targeting of activin receptor-like kinase 1 impairs tumor growth and angiogenesis.

Authors:  Sara I Cunha; Evangelia Pardali; Midory Thorikay; Charlotte Anderberg; Lukas Hawinkels; Marie-José Goumans; Jasbir Seehra; Carl-Henrik Heldin; Peter ten Dijke; Kristian Pietras
Journal:  J Exp Med       Date:  2010-01-11       Impact factor: 14.307

10.  Aberrant herpesvirus-induced polyadenylation correlates with cellular messenger RNA destruction.

Authors:  Yeon J Lee; Britt A Glaunsinger
Journal:  PLoS Biol       Date:  2009-05-26       Impact factor: 8.029

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.